Double maintains 2 strategies that include VNDA - Vanda Pharmaceuticals, Inc.
Yahoo
Over the last 7 days, the United States market has experienced a 3.0% drop, yet it remains up by 7.5% over the past year with earnings anticipated to grow by 14% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves focusing on companies that exhibit strong innovation and adaptability to capitalize on these projected earnings growth trends.
Yahoo
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) requesting marketing approval of Bysanti™ (milsaperidone) for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti™.
Yahoo
Over the last 7 days, the United States market has dropped 4.8%, yet it has risen by 15% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential through innovation and adaptability to leverage these market dynamics effectively.
Yahoo
As February 2025 unfolds, the U.S. stock market has shown signs of resilience with the S&P 500 and Nasdaq Composite inching higher after a four-day losing streak, despite ongoing concerns about the economic outlook. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their affordability and potential for growth. While traditionally viewed with caution, these stocks can offer unique opportunities when backed by strong...
Yahoo
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article entitled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S" in Molecular Therapy Nucleic Acids1, a Cell Press partner journal, that describes the development of a novel antisense oligonucleotide (ASO) therapeutic, VCA-894A, for a patient with a rare variant in the IGHMBP2 gene causing Charcot-Marie-Tooth disease Type 2S (CMT2S).
Yahoo
Q4 2024 Vanda Pharmaceuticals Inc Earnings Call
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -17.37% | $195.31M | 0.85% |
BIL | -16.59% | $41.88B | 0.1356% |
UUP | -16.28% | $325.79M | 0.77% |
XBIL | -14.31% | $706.15M | 0.15% |
USDU | -12.87% | $206.96M | 0.5% |
CTA | -12.75% | $978.30M | 0.76% |
TPMN | -12.37% | $33.32M | 0.65% |
BTAL | -11.90% | $416.76M | 1.43% |
KRBN | -11.72% | $175.08M | 0.85% |
WEAT | -10.49% | $115.75M | 0.28% |
SGOV | -9.04% | $39.98B | 0.09% |
TAIL | -8.56% | $87.65M | 0.59% |
USO | -8.26% | $972.70M | 0.6% |
BNO | -8.23% | $99.25M | 1% |
DBE | -8.13% | $55.52M | 0.77% |
TBLL | -8.09% | $2.13B | 0.08% |
DUSB | -7.14% | $1.15B | 0.15% |
USL | -6.97% | $47.77M | 0.85% |
UGA | -6.91% | $87.23M | 0.97% |
KMLM | -6.40% | $218.49M | 0.9% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LRN | 0.02% | $5.71B | +112.31% | 0.00% |
ALNY | -0.02% | $34.71B | +76.91% | 0.00% |
FUBO | 0.03% | $1.08B | +101.92% | 0.00% |
MSGS | -0.04% | $4.78B | +8.73% | 0.00% |
THS | 0.07% | $1.32B | -29.19% | 0.00% |
MG | 0.07% | $322.42M | +7.00% | 0.00% |
NTNX | 0.07% | $19.03B | +12.91% | 0.00% |
SITC | -0.08% | $675.30M | +17.17% | 1.08% |
MED | -0.09% | $149.41M | -59.89% | 0.00% |
USM | -0.09% | $5.93B | +89.17% | 0.00% |
RXO | -0.10% | $3.19B | -9.11% | 0.00% |
CNC | -0.11% | $30.13B | -16.85% | 0.00% |
WRAP | 0.14% | $76.17M | -24.55% | 0.00% |
MVO | -0.14% | $64.63M | -49.96% | 23.78% |
IFRX | -0.14% | $77.20M | -25.81% | 0.00% |
VERX | -0.17% | $5.86B | +15.18% | 0.00% |
EPM | -0.18% | $176.41M | -17.60% | 9.93% |
MIRM | -0.19% | $2.21B | +81.89% | 0.00% |
EVGO | 0.19% | $353.84M | +19.91% | 0.00% |
VRSK | 0.19% | $42.04B | +29.74% | 0.53% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 53.51% | $48.38M | 0.69% |
RSPA | 42.05% | $292.67M | 0% |
EFAA | 30.58% | $100.03M | 0% |
CETH | 28.69% | $10.49M | 0% |
ETHW | 28.59% | $178.76M | 0% |
ETHA | 28.55% | $2.27B | 0.25% |
QETH | 28.44% | $14.36M | 0.25% |
FETH | 28.32% | $762.75M | 0.25% |
QQA | 28.30% | $187.77M | 0% |
EZET | 28.26% | $22.46M | 0% |
ETHV | 28.25% | $87.97M | 0% |
BTC | 28.21% | $3.28B | 0.15% |
ETH | 28.09% | $1.29B | 0% |
FMAT | 25.11% | $439.31M | 0.084% |
VAW | 24.75% | $2.66B | 0.09% |
MXI | 24.25% | $229.91M | 0.42% |
XLB | 24.12% | $5.27B | 0.09% |
IWC | 23.45% | $797.08M | 0.6% |
MTBA | 23.23% | $1.63B | 0.17% |
IYM | 23.13% | $506.07M | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
STPZ | -0.05% | $427.83M | 0.2% |
MINT | -0.25% | $13.22B | 0.35% |
FLDR | 0.37% | $775.30M | 0.15% |
XONE | -0.53% | $631.21M | 0.03% |
FMF | -0.57% | $154.59M | 0.95% |
USFR | 0.75% | $18.53B | 0.15% |
CLOI | 0.75% | $1.01B | 0.4% |
PALL | -0.82% | $376.00M | 0.6% |
STIP | 1.04% | $11.45B | 0.03% |
ICSH | 1.06% | $5.64B | 0.08% |
JAAA | 1.20% | $21.29B | 0.21% |
VTIP | 1.30% | $13.72B | 0.03% |
IBMN | 1.38% | $472.63M | 0.18% |
FLRN | -1.39% | $2.84B | 0.15% |
EQLS | 1.40% | $4.80M | 1% |
FBY | 1.43% | $151.21M | 1.06% |
FTSM | -1.53% | $6.38B | 0.45% |
IVOL | -1.57% | $476.36M | 1.02% |
TBIL | 1.71% | $5.39B | 0.15% |
JUCY | 1.78% | $306.51M | 0.6% |
Current Value
$4.431 Year Return
Current Value
$4.431 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGS | -13.63% | $500.47M | +38.15% | 0.00% |
DDS | -12.23% | $5.79B | -10.22% | 0.31% |
COTY | -9.10% | $4.93B | -48.12% | 0.00% |
PRPO | -9.02% | $8.36M | -11.96% | 0.00% |
IMNN | -8.98% | $15.35M | -24.46% | 0.00% |
SCM | -8.68% | - | - | 11.70% |
NXTC | -8.59% | $11.20M | -83.33% | 0.00% |
CPB | -8.55% | $11.75B | -8.27% | 3.73% |
ULTA | -7.89% | $17.33B | -13.06% | 0.00% |
TCTM | -7.73% | $3.92M | -82.22% | 0.00% |
UFI | -7.71% | $89.19M | -14.89% | 0.00% |
REYN | -7.46% | $5.04B | -15.41% | 3.82% |
DIS | -6.89% | $176.95B | -17.73% | 1.04% |
CNXC | -6.38% | $3.49B | -5.71% | 2.56% |
UTZ | -6.37% | $1.21B | -19.18% | 1.64% |
KIRK | -6.28% | $17.18M | -44.26% | 0.00% |
CBOE | -6.10% | $23.50B | +25.53% | 1.05% |
HIHO | -5.79% | $7.92M | -15.09% | 6.67% |
QTTB | -5.75% | $18.11M | -93.02% | 0.00% |
POAI | -5.75% | $10.09M | -28.57% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ORKA | 38.99% | $352.69M | -55.09% | 0.00% |
TEM | 38.01% | $8.59B | 0.00% | 0.00% |
SUNS | 31.15% | $146.83M | -3.19% | 8.82% |
CLDX | 28.44% | $1.15B | -56.93% | 0.00% |
SUN | 26.76% | $8.06B | -1.02% | 6.07% |
REPL | 26.58% | $663.87M | +22.10% | 0.00% |
CYRX | 26.07% | $307.45M | -66.41% | 0.00% |
AVNT | 25.00% | $3.47B | -12.52% | 3.12% |
NUVL | 24.85% | $5.04B | -4.78% | 0.00% |
TTC | 24.84% | $7.37B | -15.13% | 2.16% |
HIPO | 24.51% | $622.03M | +13.61% | 0.00% |
QXO | 24.35% | $6.03B | -83.01% | 0.00% |
ZYME | 24.33% | $836.16M | +23.78% | 0.00% |
GENI | 24.31% | $2.46B | +81.24% | 0.00% |
KSPI | 24.22% | $17.96B | -30.04% | 4.03% |
CC | 23.89% | $1.95B | -54.54% | 8.68% |
AORT | 23.84% | $1.05B | +16.78% | 0.00% |
HALO | 23.74% | $7.79B | +56.65% | 0.00% |
CODX | 23.68% | $12.02M | -68.04% | 0.00% |
OPEN | 23.60% | $730.75M | -64.81% | 0.00% |